MGH Gordon PET Core
The PET Core provides a full range of technical and professional services for the design and execution of programs using Positron Emission Tomography (PET).
- PET and SPECT animal and human imaging
- Synthesis of radiotracers and radiopharmaceuticals
- Experimental design and pharmacokinetic modeling
- Validation and regulatory submission of compound for human use
- Automated Radiochemical Synthesis Systems
- PC4096 Large Bore PET Scanner
- Exact HR+ Large Bore PET Scanner
- E.cam (Siemens) SPECT Systems and Planar Gamma Cameras
- Siemens PET/CT Scanner, Symbia SPECT/CT
- NeuroPET/CT dedicated high sensitivity brain scanner
- VISTA small animal micro PET/CT
For further information please follow this link: gordon.mgh.harvard.edu/gc/mgh-pet-core/
Director, MGH Gordon PET Core & Co-Director, Division of Nuclear Medicine & Molecular Imaging: Georges El Fakhri, Ph.D.
Phone: (617) 726-9640
Fax: (617) 726-6165
Manager, PET Production Chemistry: Daniel Yokell, Pharm.D.
Phone: (617) 643-7541
Fax: (617) 726-5123
For inquiries regarding our services and fees, please contact:
Financial Manager: Ramsey El Fakhri
Phone: (617) 724-7212
The cyclotron/radiochemistry component of the PET Core is located in the basement of the Edwards Building. The PET Research Imaging Laboratories consist of imaging cameras for human and large-animals imaging including a dedicated brain PET/CT and whole body PET, PET/CT and SPECT/CT on the MGH Main Campus, as well as a dedicated MicroPET/CT for animal imaging located at the Charlestown Navy Yard.
Our services are available to all users within the Partners system and to outside users as well. Research services are accessed through contact with the professional staff leading to formalization of a research plan and subsequent review by the Scientific Management Committee. Clinical services are accessed by direct arrangement with the medical staff of the radiology department.
We always commit our best efforts to successfully complete scheduled studies. However, given the very nature of many PET studies that rely on manufacturing of the radiopharmaceutical and in vivo imaging, we cannot cover costs associated with uncompleted studies due to equipment failure or circumstances outside of our control.